Cleveland, OH, United States of America

Robyn Marks

This inventor holds 1 USPTO granted patent. Top assignee: Case Western Reserve University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robyn Marks. Retrieved from https://idiyas.com/inventor/robyn-marks-goxj0yaj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robyn Marks: Innovator in Hydrogel Technology

Introduction

Robyn Marks is a prominent inventor based in Cleveland, OH (US). She has made significant contributions to the field of tissue engineering and bioprinting. Her innovative work focuses on developing advanced hydrogels that can enhance medical applications.

Latest Patents

Robyn Marks holds 1 patent for her invention titled "Hydrogel for tissue engineering and bioprinting." This composition includes a hydrogel that consists of a plurality of biodegradable natural polymer macromers crosslinked with a first agent. Additionally, it may contain a plurality of cells dispersed in the crosslinked macromers. The microgels are capable of being crosslinked with a second agent that is different from the first crosslinking agent.

Career Highlights

Robyn Marks is affiliated with Case Western Reserve University, where she continues to advance her research in hydrogel technology. Her work has the potential to revolutionize the way tissues are engineered and printed for medical purposes.

Collaborations

Robyn collaborates with esteemed colleagues such as Eben Alsberg and Oju Jeon, who contribute to her research endeavors and help expand the impact of her innovations.

Conclusion

Robyn Marks is a trailblazer in the field of hydrogel technology, with her patent paving the way for future advancements in tissue engineering and bioprinting. Her contributions are vital to the ongoing evolution of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…